$3M Tax Break Promise Convinces OSI Pharma to Consolidate, Expand in NYC Suburb | GenomeWeb

By Alex Philippidis

WHITE PLAINS, NY — OSI Pharmaceuticals this week was promised $3 million in sales tax breaks from New York state and Westchester County governments to help pay for its $100 million consolidation of its US operations and expansion in Greenburgh, NY.

At the same time, additional details emerged about the tax incentives and about the search that ended in the New York City suburb located less than an hour's drive north of Manhattan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.